We report on two patients who experienced emergence of full manic symptoms while receiving vagal nerve stimulation (VNS).
| INTRODUCTION
Vagus nerve stimulation (VNS; electrical stimulation of the left cervical vagus nerve by an implanted pulse generator) is used extensively throughout the world and is clinically very well tolerated. Initially VNS was employed in patients with refractory partial epilepsy.
1 During these studies, it was noted that patients with epilepsy who had VNS devices implanted experienced improvement in their depressive symptoms independent of the effects of reduced seizures. 2, 3 In 2000, the first open-label studies of VNS in treatment-refractory major depression (TRMD) were published. 4 Subsequently, a large multicenter, double-blind, placebo-controlled trial failed to demonstrate efficacy; 5 however, the open-label extension of this study demonstrated that a longer period of stimulation (minimum of 6 months)
is required for efficacy, with response rates of 24.9%, 27.7%, and
36.5% at 6, 9, and 12 months, respectively. The mechanism of action underlying the antidepressant properties of VNS remains unclear. However, results from preclinical studies demonstrate that the effects of VNS fall within the context of two hypotheses central to the pathophysiology of depression: monoaminergic neurotransmission and neural plasticity. 11 VNS has been shown to increase the firing rates of noradrenergic and serotonergic neurons in the locus coeruleus (LC) and dorsal raphe nucleus (DRN), respectively. 12, 13 Supplementing these findings is the association of VNS with an increase in norepinephrine concentrations in areas of the brain with key roles in the pathophysiology of depression, including the amygdala, hippocampus, and prefrontal cortex. 14-16 VNS likely also activates central cholinergic pathways, which have been demonstrated to be involved in depression. 17, 18 Furthermore, animal studies show that VNS promotes hippocampal neurogenesis, 19 and increases brain-derived neurotrophic factor (BDNF) levels and dendritic complexity in hippocampal neurons.
20
Finally, positron emission tomography studies of sustained VNS suggest activation of brainstem dopaminergic regions. 21 All of these changes tend to occur after chronic VNS, offering a plausible hypothesis for the delayed onset of its antidepressant effect seen in clinical studies. 22, 23 VNS is generally well tolerated; 6 however, there have been several reported cases, in both epilepsy and TRMD, of manic emergence. 6, 9, [23] [24] [25] [26] This report details two patients, both with a well-documented and verified history of longstanding unipolar depression, who experienced emergence of full manic symptoms while receiving VNS.
| NARRATIVE

| Case 1
Mr. S is a 58-year-old Caucasian man with a history of depressive 
| Case 2
Ms. W is a 43-year-old Caucasian woman with a prolonged history of depression with initial psychiatric contact for major depressive dis- improved mood and her VNS was turned on again at a low setting, which she tolerated well. Since this time, she has continued to be on maintenance mood stabilizer therapy and has maintained euthymia.
| DISCUSSION
Mania/hypomania are known, albeit rare, events associated with VNS. Here we present two individuals with a longstanding history of Manic emergence during VNS may be more common and earlier in onset in patients with a prior history of manic/hypomanic episodes vis-à-vis patients with no such prior history. In the two cases described in this report, the onset of manic/hypomanic symptoms was quite delayed (8 months for Mr. S and 9 months for Ms. W). Rush et al. 6 observed that, among the three subjects who developed mania with VNS stimulation, there was a chronological time difference between those with a history of hypomania/mania, and those without. In the two subjects with bipolar disorder, emergence of mania occurred within 3 months and symptoms resolved spontaneously within 1−2 weeks.
Manic emergence was delayed (>3 months post-VNS activation) in the subject with unipolar MDD. VNS stimulation was halted for the duration of the manic episode (2 months) for this subject.
From a mood disorders standpoint, what could explain the emergence of mania in the two middle-aged patients with unipolar depression? One plausible explanation is the possibility that these seemingly unipolar depressive patients were, in fact, "masked bipolar," ie, they carried a propensity for recurrent depressive mood episodes, but were yet to "declare" themselves bipolar until they underwent sustained VNS.
This explanation would be similar to previously reported evidence of antidepressants inducing a switch from a depressed to a manic/hypomanic state, 27 with some medications suggested to be more likely to induce these switches. 28 Yet, the two subjects presented in this case report were tried on numerous antidepressants from different classes (and ECT in one of the subjects) without ever experiencing any manic symptoms. This suggests that biological changes underlying the mechanism of action of VNS may be different from those occurring with other antidepressant modalities. To illustrate this point, VNS has been shown to modulate neural plasticity and cortical excitability through activation of central cholinergic pathways, making it distinct from conventional antidepressants' mode of action at the circuitry level. 29, 30 Despite the pre-existing hypothesis of a pro-cholinergic state leading to depression, 17 recent evidence of cholinesterase inhibitors inducing mania challenges this notion. 31 The role of the central cholinergic system in mood regulation may be more complex and nuanced than previously thought. Taken together, findings suggest that manic emergence occurring with VNS may partly be related to its central pro-cholinergic effect, although this hypothesis still needs further investigation.
The antidepressant properties of VNS have also been linked to increased dopaminergic activity. VNS has been associated with increased cerebrospinal fluid homovanillic acid, reflecting increased brain dopamine metabolism, in subjects with TRMD. 32 In a more recent study on TRMD subjects, increased ventral tegmental area activity was observed in VNS-responders after 12 months. 21 Although preliminary, these findings suggest that increased dopamine function may be playing a salient role in the antidepressant effect of VNS.
The observation of the emergence of mania with VNS in treating TRMD further supports the theory that VNS is acting as an antidepressant in TRMD, as most other antidepressant modalities (medications, ECT and sleep deprivation) have been associated with hypomanic/ manic emergence. 33 
| CONCLUSIONS
As discussed earlier, manic symptoms were adequately managed with standard treatments (mood stabilizer and ECT) along with some adjustments in the VNS parameters. Subsequently, we were able to continue VNS in the two subjects for up to 5 years without any further occurrences of manic/hypomanic episodes. This report provides evidence that manic switches, however serious and troubling to patients, can be managed safely, and that VNS maintenance can be continued for an extended period of time without any manic relapses.
